𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I/II study of recombinant interferon α and γ in advanced progressive renal-cell carcinoma

✍ Scribed by Pieter H. M. de Mulder; Frans M. J. Debruyne; Mart P. H. Franssen; Arno D. H. Geboers; Simon Strijk; Ad G. M. Reintjes; Wim H. Doesburg; Otto Damsma

Publisher
Springer-Verlag
Year
1990
Tongue
English
Weight
585 KB
Volume
31
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of recombinant beta inter
Phase II study of recombinant beta interferon in patients with advanced non-small-cell lung carcinoma
✍ Ettinger, David S. ;Harwood, Kerry 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Eighteen patients with advanced non-smallcell lung cancer (NSCLC) received recombinant beta interferon, 90 million units three times weekly. No complete or partial responses were seen. Five patients had stable disease for several months. Most patients experienced some toxicity, most commonly fever a

A phase II trial of interferon-α and 5-f
A phase II trial of interferon-α and 5-fluorouracil in patients with advanced renal cell carcinoma: A Southwest Oncology Group study
✍ Laurence Elias; Brent A. Blumenstein; Julie Kish; Robert C. Flanigan; James L. W 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 1 views

## BACKGROUND. Renal cell carcinoma is a common neoplasm that is often refractory to treatment. It is occasionally responsive to immunoniodulating agents including interferon-a, which enhances the effects of 5-fluorouracil upon cells. Combinations of these two drugs have been most frequently tested